Improving language skills in minimally verbal children with autism
Predicting and Optimizing Language Outcomes in Minimally Verbal Children with Autism Spectrum Disorder
This study is looking at ways to help children with Autism Spectrum Disorder who have trouble speaking, by understanding how their bodies and brains work when they communicate, so we can find the best ways to support their language development during those important early school years.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10689688 on NIH RePORTER |
What this research studies
This research investigates how to enhance language development in children with Autism Spectrum Disorder (ASD) who are minimally verbal. By examining the motor and neural mechanisms that contribute to their communication challenges, the study aims to identify which children are likely to benefit from targeted behavioral interventions. The research employs a multidisciplinary approach, utilizing advanced technologies and methods from various fields such as communication disorders and neuroscience. The ultimate goal is to facilitate language acquisition during the critical early school years for these children.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years diagnosed with Autism Spectrum Disorder who are minimally verbal.
Not a fit: Patients who are verbally proficient or do not have a diagnosis of Autism Spectrum Disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective interventions that significantly improve communication skills in minimally verbal children with autism.
How similar studies have performed: Previous research has shown promise in using targeted behavioral interventions to improve communication in similar populations, indicating that this approach may be effective.
Where this research is happening
Boston, United States
- Boston University (Charles River Campus) — Boston, United States (Active)
Researchers
- Principal investigator: Tager-Flusberg, Helen — Boston University (Charles River Campus)
- Study coordinator: Tager-Flusberg, Helen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.